Cargando…

Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies

Sorafenib is the first-line treatment of choice for advanced hepatocellular carcinoma (HCC). However, the benefits of sorafenib in HCC patients with portal vein tumour thrombosis (PVTT) remain uncertain. Until now, a total of eight comparative studies have been identified for this systematic review....

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Xingshun, Guo, Xiaozhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607698/ https://www.ncbi.nlm.nih.gov/pubmed/26516379 http://dx.doi.org/10.5114/pg.2015.52470

Ejemplares similares

Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib
por: Kermiche-Rahali, Sabrina, et al.
Publicado: (2013)

No Association between Ischemic Stroke and Portal Vein Thrombosis in Liver Cirrhosis
por: Zheng, Kexin, et al.
Publicado: (2020)

Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
por: Jeong, Soung Won, et al.
Publicado: (2013)

Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis
por: Dai, Junna, et al.
Publicado: (2015)

Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma
por: Li, Zhenli, et al.
Publicado: (2023)

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
por: Lee, Jung Min, et al.
Publicado: (2016)

Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kim, Jina, et al.
Publicado: (2022)

Transient portal vein thrombosis in liver cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2018)

Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis
por: Que, Jenny, et al.
Publicado: (2020)

Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature
por: Qi, Xingshun, et al.
Publicado: (2015)

Combination Intensity-Modulated Radiotherapy and Sorafenib Improves Outcomes in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Abulimiti, Munire, et al.
Publicado: (2021)

Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy
por: Kim, Pyeong Hwa, et al.
Publicado: (2019)

Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study
por: Cao, Yanyan, et al.
Publicado: (2021)

An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty
por: Qi, Xingshun, et al.
Publicado: (2016)

A Large Portal Vein: A Rare Finding of Recent Portal Vein Thrombosis
por: Qi, Xingshun, et al.
Publicado: (2011)

Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Deng, Min, et al.
Publicado: (2023)

Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Ahn, Young Eun, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature
por: Qi, Xingshun, et al.
Publicado: (2011)

Portal hypertension complicating myelofibrosis in a patient without portal or hepatic vein thrombosis
por: Qi, Xingshun, et al.
Publicado: (2014)

Early Experience of Oncolytic Virus Injection Combined with Sorafenib in a Patient with Advanced Hepatocellular Carcinoma and Portal Vein Thrombosis
por: Jo, Hyun Ho, et al.
Publicado: (2020)

Surgical management in hepatocellular carcinoma with portal vein tumour thrombosis: is this the end of the road or a chance to expand the criteria for resectability?
por: Benatatos, Nikolaos, et al.
Publicado: (2022)

Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis
por: Wang, Le, et al.
Publicado: (2020)

Evolution of Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis: A Pictorial Review
por: Xu, Shixue, et al.
Publicado: (2021)

Pharmacologic Prophylaxis of Portal Venous System Thrombosis after Splenectomy: A Meta-Analysis
por: Qi, Xingshun, et al.
Publicado: (2014)

Transarterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Prognostic Factors in a Single-Center Study of 188 Patients
por: Liu, Lei, et al.
Publicado: (2014)

Prevalence of Splanchnic Vein Thrombosis in Pancreatitis: A Systematic Review and Meta-Analysis of Observational Studies
por: Xu, Wenda, et al.
Publicado: (2015)

New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
por: Woo, Hyun Young, et al.
Publicado: (2015)

Folate levels in hepatocellular carcinoma patients with portal vein thrombosis
por: Malaguarnera, Giulia, et al.
Publicado: (2020)

Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides
por: Khan, Abdul Rehman, et al.
Publicado: (2021)

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Zane, Kylie E., et al.
Publicado: (2021)

Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis
por: Kim, Sang Jin, et al.
Publicado: (2021)

Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib
por: Kee, Kwong-Ming, et al.
Publicado: (2014)

Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply
por: Yim, Hyung Joon, et al.
Publicado: (2023)

The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy
por: Bae, Bong Kyung, et al.
Publicado: (2016)

Association of C-type lectin-like receptor 2 and galectin-1 with portal vein system thrombosis in HBV-related liver cirrhosis
por: Zhang, Yiyan, et al.
Publicado: (2023)

Tolerability and efficacy of gamma knife radiosurgery on hepatocellular carcinoma with portal vein tumor thrombosis
por: Lu, Xiao-Jie, et al.
Publicado: (2015)

Associations of Antiphospholipid Antibodies With Splanchnic Vein Thrombosis: A Systematic Review With Meta-Analysis
por: Qi, Xingshun, et al.
Publicado: (2015)

Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
por: Nakazawa, Takahide, et al.
Publicado: (2014)

Case Report: Pancreatic Neuroendocrine Tumor With Liver Metastasis and Portal Vein Thrombosis
por: Tian, Yulong, et al.
Publicado: (2022)

Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis
por: Qi, Xingshun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qechg2r1p4pdbrviv857lqnh4a